Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Reactive oxygen species (ROS) and lipid-derived free radicals are highly reactive chemical entities that play a dual role in cellular physiology, acting as signaling molecules at low levels and as destructive agents at high levels. In the context of lipophilic membranes, these radicals, particularly lipid peroxyl radicals, initiate and propagate lipid peroxidation, a process that damages the structural integrity of the lipid bilayer (Ayala et al., 2014, PMID: 24903214). This oxidative degradation is a central feature of ferroptosis, a non-apoptotic form of regulated cell death linked to various pathological states (Dixon et al., 2012, PMID: 22632970). Therapeutic targeting of these species involves the use of lipophilic antioxidants, such as Vitamin E, and synthetic radical-trapping agents like Ferrostatin-1, which localize to the membrane to terminate radical chain reactions (Traber & Stevens, 2011, PMID: 21865568). These interventions are being explored for treating neurodegenerative diseases, cardiovascular disorders, and acute organ injuries where oxidative stress is a primary driver. However, a significant challenge in targeting these radicals is the potential to disrupt essential redox-sensitive signaling pathways required for normal cell function. Effective drug design must therefore balance the neutralization of harmful radicals with the preservation of physiological signaling.
Radical scavenging and chain-breaking antioxidant activity within the lipid bilayer to prevent the propagation of lipid peroxidation.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Reactive oxygen species and lipid-derived free radicals in lipophilic membranes (ROS/LFR).